Literature DB >> 9269834

Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.

M A Scott1, M D Lagios, K Axelsson, L W Rogers, T J Anderson, D L Page.   

Abstract

Historically, two major strata of ductal carcinoma in situ (DCIS) have been linked to outcome, the presence or absence of comedo type and size. Our initial approach in classification was dichotomous, often favoring the comedo type with most worrisome implications to foster agreement in diagnosis. We have now tested guidelines that foster agreement in the modified Lagios three-tiered system. Sixteen cases of DCIS were selected, reflecting a spectrum of histological subtypes, with specific inclusion of cases in which consensus in classification using a dichotomous (comedo/noncomedo) scheme would be difficult. Six independent observers reviewed a minimum of five color 35-mm slides from each case at two separate occasions. The aim was to subclassify each case based on architectural pattern, nuclear grade, and presence or absence of tumor necrosis (Modified Lagios Classification, Lagios et al, Cancer 1989). After initial review, emphasizing placement of each case into a high- or low-grade category, there was disagreement in seven cases (44%), confirming our aim to choose cases with uncertain cues for classification. Agreement was achieved in 94% of cases by allowing re-review with emphasis on inclusion of an intermediate-grade category. Our study also suggests that pure micropapillary DCIS and apocrine DCIS warrant independent classification as "special type" DCIS. Our small pilot study suggests that, with adherence to specific criteria, most DCIS cases can be easily and consistently classified into the following five categories: (1) high grade, (2) intermediate grade, (3) low grade, (4) pure or predominantly micropapillary, and (5) pure apocrine. Our six observers independently reached a final concordance of 94% despite selection of cases in which consensus in a dichotomous classification was difficult. This was achieved predominantly by accepting an intermediate category of DCIS with intermediate nuclear features and limited necrosis. Confirmation of the applicability of the Modified Lagios Classification awaits completion of a much larger multi-institutional study in which statistical significance and interobserver variation can be better defined.

Entities:  

Mesh:

Year:  1997        PMID: 9269834     DOI: 10.1016/s0046-8177(97)90013-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?

Authors:  P H Tan; B C-S Ho; S Selvarajan; W M Yap; A Hanby
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

Review 2.  Electron microscopic findings for diagnosis of breast lesions.

Authors:  Shin-ichi Tsuchiya; Fu Li
Journal:  Med Mol Morphol       Date:  2005-12       Impact factor: 2.309

3.  Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.

Authors:  Kalliopi P Siziopikou; Stewart J Anderson; Melody A Cobleigh; Thomas B Julian; Douglas W Arthur; Ping Zheng; Eleftherios P Mamounas; Eduardo R Pajon; Robert J Behrens; Janice F Eakle; Nick C Leasure; James N Atkins; Jonathan A Polikoff; Thomas E Seay; Worta J McCaskill-Stevens; Rachel Rabinovitch; Joseph P Costantino; Norman Wolmark
Journal:  Breast Cancer Res Treat       Date:  2013-11-08       Impact factor: 4.872

Review 4.  Gastric precancerous lesions: heading for an international consensus.

Authors:  R M Genta; M Rugge
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

5.  The diagnostic challenge of low-grade ductal carcinoma in situ.

Authors:  Tracy Onega; Donald L Weaver; Paul D Frederick; Kimberly H Allison; Anna N A Tosteson; Patricia A Carney; Berta M Geller; Gary M Longton; Heidi D Nelson; Natalia V Oster; Margaret S Pepe; Joann G Elmore
Journal:  Eur J Cancer       Date:  2017-05-20       Impact factor: 9.162

Review 6.  Significance of rat mammary tumors for human risk assessment.

Authors:  Jose Russo
Journal:  Toxicol Pathol       Date:  2014-05-28       Impact factor: 1.902

Review 7.  Non-operative breast pathology: apocrine lesions.

Authors:  C A Wells; G A El-Ayat
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

8.  Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast.

Authors:  Amanda Arantes Perez; Rafael Malagoli Rocha; Débora Balabram; Átila da Silva Souza; Helenice Gobbi
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

9.  Ductal carcinoma in situ: what the pathologist needs to know and why.

Authors:  Anita Bane
Journal:  Int J Breast Cancer       Date:  2013-02-06

10.  Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast.

Authors:  R R Millis; S E Pinder; K Ryder; R Howitt; S R Lakhani
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.